PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosis

Background: Protein arginine methyltransferase 4 (PRMT4) has been reported to play a role in several common cancers; however, the function and mechanism of PRMT4 in hepatocellular carcinoma (HCC) are not fully understood. This study aimed to investigate the role and mechanism of PRMT4 in the progres...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Peng, Luo, Kaifeng, Li, Guoyong, Zhu, Jisheng, Xiao, Qi, Li, Yong, Zhang, Xingjian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436100/
https://www.ncbi.nlm.nih.gov/pubmed/34522186
http://dx.doi.org/10.7150/ijms.62467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436100/
https://www.ncbi.nlm.nih.gov/pubmed/34522186
http://dx.doi.org/10.7150/ijms.62467

Ejemplares similares